What is Altimmune's change in AR?

Altimmune (ALT) reported change in AR of $446K in Q1 2026.

How has Altimmune's change in AR changed year-over-year?

Altimmune's change in AR increased by 1305.4% year-over-year, from -$37K to $446K.

What is the long-term trend for Altimmune's change in AR?

Over 3 years (2021 to 2025), Altimmune's change in AR has grown at a -45.5% compound annual growth rate (CAGR), from -$4.18M to $675K.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Altimmune ALT Change in AR

Change in AR at other companies

Merck & Co.MRK

$272.5M+347%

Madrigal Pharmaceuticals, Inc.MDGL

$52.88M+595%

Wave Life SciencesWVE

-$1.28M+10.3%

Delcath SystemsDCTH

$2.42M-20.9%

Mirum Pharmaceuticals, Inc.MIRM

$12.89M-23.4%

Travere Therapeutics, Inc.TVTX

$7.23M+0.3%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's change in AR?: Altimmune (ALT) reported change in AR of $446K in Q1 2026.
How has Altimmune's change in AR changed year-over-year?: Altimmune's change in AR increased by 1305.4% year-over-year, from -$37K to $446K.
What is the long-term trend for Altimmune's change in AR?: Over 3 years (2021 to 2025), Altimmune's change in AR has grown at a -45.5% compound annual growth rate (CAGR), from -$4.18M to $675K.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.